ZyVersa Therapeutics Announces Article Published in Peer-Reviewed Biomedical Journal Demonstrating That NLRP3 Inflammasome Inhibition Attenuates Inflammatory Bowel Disease Symptoms in Animal Model

<p>Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract affecting 1 in 100 Americans (around 2.4 million people) that can lead to disabling bowel symptoms and progressive bowel damage. Study provides direct evidence that NLRP3 signaling is over-activated in IBD, and that its inhibition attenuates intestinal inflammation and tissue damage, leading […]</p>
<p>The post <a href="https://forextv.com/top-news/zyversa-therapeutics-announces-article-published-in-peer-reviewed-biomedical-journal-demonstrating-that-nlrp3-inflammasome-inhibition-attenuates-inflammatory-bowel-disease-symptoms-in-animal-model/">ZyVersa Therapeutics Announces Article Published in Peer-Reviewed Biomedical Journal Demonstrating That NLRP3 Inflammasome Inhibition Attenuates Inflammatory Bowel Disease Symptoms in Animal Model</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>